Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-25-000017
Filing Date
2025-01-03
Accepted
2025-01-03 16:17:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7665
  Complete submission text file 0001535610-25-000017.txt   9303
Mailing Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109
Business Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109 646-307-4500
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Subject) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91842 | Film No.: 25506491
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)